WAM
AGIO icon

Weiss Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Weiss Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,462
Closed -$575K – 455
2018
Q3 		$575K Sell
7,462
-758
-9% -$61K 0.04% 117
2018
Q2 		$692K Buy
8,220
+758
+10% +$66.1K 0.07% 106
2018
Q1 		$610K Hold
7,462
– – 0.05% 109
2017
Q4 		$427K Buy
7,462
+4,465
+149% +$281K 0.04% 137
2017
Q3 		$200K Buy
+2,997
New +$180K 0.02% 93

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Weiss Asset Management's AGIO Position: Q4 2018 in Review

Weiss Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2018, closing a stake of 7,462 shares — an estimated $575K sold.

Weiss Asset Management first reported a position in AGIO in Q3 2017 and held it in 5 quarters. The position peaked at $692K in Q2 2018. 196 funds tracked by Wall St. Rank hold AGIO as of Q4 2018.

  • Weiss Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Weiss Asset Management sold 7,462 Agios Pharmaceuticals shares in Q4 2018, an estimated $575K.
  • Weiss Asset Management first reported a position in Agios Pharmaceuticals in Q3 2017 and held it in 5 quarters.
  • Weiss Asset Management's Agios Pharmaceuticals position peaked at $692K in Q2 2018.
  • 196 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2018.

Based on Weiss Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.